$SLNO
SOLENO THERAPEUTICS INC

2017 Q2 Form 10-Q Financial Statement

#000162828017005423 Filed on May 11, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2017 Q1 2016 Q4
Revenue $1.000K $265.0K $0.00
YoY Change -50.0% -40.72% -100.0%
Cost Of Revenue $42.00K $209.0K
YoY Change -17.65% -54.66%
Gross Profit -$41.00K $56.00K
YoY Change -16.33% -500.0%
Gross Profit Margin -4100.0% 21.13%
Selling, General & Admin $2.195M $1.046M $1.540M
YoY Change 38.22% -57.77% -30.32%
% of Gross Profit 1867.86%
Research & Development $773.0K $327.0K $290.0K
YoY Change 17.48% -81.55% -77.34%
% of Gross Profit 583.93%
Depreciation & Amortization $420.0K $150.0K $40.00K
YoY Change 950.0% 650.0% -33.33%
% of Gross Profit 267.86%
Operating Expenses $2.968M $1.373M $1.830M
YoY Change 32.15% -67.69% -47.56%
Operating Profit -$2.968M -$1.373M
YoY Change 29.32% -67.79%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$88.00K -$672.0K $410.0K
YoY Change 22.22% -162.57% -37.88%
Pretax Income -$3.060M -$2.050M -$1.420M
YoY Change 94.9% 4.06% -50.0%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$3.969M -$2.887M -$2.610M
YoY Change 12.98% -9.47% -8.1%
Net Earnings / Revenue -396900.0% -1089.43%
Basic Earnings Per Share
Diluted Earnings Per Share -$417.0K -$567.8K -$818.2K
COMMON SHARES
Basic Shares Outstanding 47.59M shares 47.48M shares 15.76M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2017 Q1 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.550M $10.54M $2.730M
YoY Change 202.0% 62.4% -50.27%
Cash & Equivalents $7.547M $10.54M $2.726M
Short-Term Investments
Other Short-Term Assets $2.610M $300.0K $290.0K
YoY Change 1205.0% 15.38% 38.1%
Inventory $164.0K $855.0K $0.00
Prepaid Expenses
Receivables $3.000K $110.0K $3.000K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $10.32M $11.80M $3.801M
YoY Change 174.71% 55.61% -40.64%
LONG-TERM ASSETS
Property, Plant & Equipment $53.00K $93.00K $42.02K
YoY Change -55.08% -23.14% -50.99%
Goodwill $718.0K $718.0K
YoY Change 0.0% -21.68%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $126.0K $126.0K $125.5K
YoY Change 65.79% 65.79% -82.52%
Total Long-Term Assets $20.06M $22.07M $1.764M
YoY Change 1027.77% 1121.08% -1.86%
TOTAL ASSETS
Total Short-Term Assets $10.32M $11.80M $3.801M
Total Long-Term Assets $20.06M $22.07M $1.764M
Total Assets $30.38M $33.87M $5.565M
YoY Change 448.89% 260.65% -32.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.029M $935.0K $410.5K
YoY Change 7.52% -25.91% -40.94%
Accrued Expenses $880.0K $1.240M $1.170M
YoY Change -6.38% -6.06% -28.22%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.122M $2.172M $1.707M
YoY Change 11.63% -15.78% -46.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.132M $1.201M $61.74K
YoY Change 466.0% 500.5% -43.57%
Total Long-Term Liabilities $1.132M $1.201M $61.74K
YoY Change 466.0% 500.5% -43.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.122M $2.172M $1.707M
Total Long-Term Liabilities $1.132M $1.201M $61.74K
Total Liabilities $3.693M $3.721M $2.130M
YoY Change 75.77% 33.9% -57.21%
SHAREHOLDERS EQUITY
Retained Earnings -$105.2M -$101.2M -$98.31M
YoY Change 13.15% 13.15% 13.99%
Common Stock $131.9M $131.3M $101.7M
YoY Change 37.98% 37.86% 13.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $26.69M $30.14M $3.435M
YoY Change
Total Liabilities & Shareholders Equity $30.38M $33.87M $5.565M
YoY Change 448.89% 260.65% -32.15%

Cashflow Statement

Concept 2017 Q2 2017 Q1 2016 Q4
OPERATING ACTIVITIES
Net Income -$3.969M -$2.887M -$2.610M
YoY Change 12.98% -9.47% -8.1%
Depreciation, Depletion And Amortization $420.0K $150.0K $40.00K
YoY Change 950.0% 650.0% -33.33%
Cash From Operating Activities -$3.000M -$2.183M -$2.690M
YoY Change -25.74% -45.21% -20.41%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $4.000K $0.00
YoY Change -100.0% -78.95% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$4.000K $0.00
YoY Change -100.0% -78.95% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $10.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 10.00M 0.000
YoY Change -100.0% 100.0% -100.0%
NET CHANGE
Cash From Operating Activities -3.000M -2.183M -2.690M
Cash From Investing Activities 0.000 -4.000K 0.000
Cash From Financing Activities 0.000 10.00M 0.000
Net Change In Cash -3.000M 7.813M -2.690M
YoY Change -24.81% 683.65% -444.87%
FREE CASH FLOW
Cash From Operating Activities -$3.000M -$2.183M -$2.690M
Capital Expenditures $0.00 $4.000K $0.00
Free Cash Flow -$3.000M -$2.187M -$2.690M
YoY Change -25.37% -45.37% -23.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 capn Additional Operating Lease Office Space
AdditionalOperatingLeaseOfficeSpace
5265 sqft
CY2016Q1 capn Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-1170000 USD
CY2017Q1 capn Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
69000 USD
CY2017Q1 capn Classof Warrant Or Right Liquidated Damages Amount Percentof Volume Weighted Average Price
ClassofWarrantOrRightLiquidatedDamagesAmountPercentofVolumeWeightedAveragePrice
0.01
CY2015Q1 capn Lessee Leasing Arrangements Operating Leases Increasesto Monthly Payments Term
LesseeLeasingArrangementsOperatingLeasesIncreasestoMonthlyPaymentsTerm
P2Y
CY2015Q3 capn Lessee Leasing Arrangements Operating Leases Increasesto Monthly Payments Term
LesseeLeasingArrangementsOperatingLeasesIncreasestoMonthlyPaymentsTerm
P3Y
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
935000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
133000 USD
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
110000 USD
CY2016Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1169000 USD
CY2017Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1237000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
101730000 USD
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
131296000 USD
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
136000 USD
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
185000 USD
CY2016Q1 capn Noncash Expense On Shares Issued
NoncashExpenseOnSharesIssued
0 USD
CY2017Q1 capn Noncash Expense On Shares Issued
NoncashExpenseOnSharesIssued
602000 USD
CY2016Q1 capn Noncashor Part Noncash Acquisition Contingent Consideration
NoncashorPartNoncashAcquisitionContingentConsideration
0 USD
CY2017Q1 capn Noncashor Part Noncash Acquisition Contingent Consideration
NoncashorPartNoncashAcquisitionContingentConsideration
1090000 USD
CY2016Q1 capn Noncashor Part Noncash Acquisition Valueof Assets Acquired But Not Yet Paid
NoncashorPartNoncashAcquisitionValueofAssetsAcquiredButNotYetPaid
0 USD
CY2017Q1 capn Noncashor Part Noncash Acquisition Valueof Assets Acquired But Not Yet Paid
NoncashorPartNoncashAcquisitionValueofAssetsAcquiredButNotYetPaid
572000 USD
CY2017Q1 capn Numberof Products Derivedfrom Proprietary Technologies
NumberofProductsDerivedfromProprietaryTechnologies
2 product
CY2017Q1 capn Sharebased Compensation Arrangementby Sharebased Payment Award Plan Amendment Numberof Additional Shares Authorized
SharebasedCompensationArrangementbySharebasedPaymentAwardPlanAmendmentNumberofAdditionalSharesAuthorized
8929188 shares
CY2017Q1 capn Stock Issued During Period Shares Debt Issuances
StockIssuedDuringPeriodSharesDebtIssuances
8333333 shares
CY2017Q1 capn Working Capital
WorkingCapital
9600000 USD
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001484565
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47587647 shares
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
Capnia, Inc.
CY2017Q1 dei Trading Symbol
TradingSymbol
CAPN
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
538000 USD
CY2015Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
8171 sqft
CY2016Q4 us-gaap Assets
Assets
5565000 USD
CY2017Q1 us-gaap Assets
Assets
33865000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
3801000 USD
CY2017Q1 us-gaap Assets Current
AssetsCurrent
11800000 USD
CY2016Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
19000 USD
CY2017Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
5000 USD
CY2017Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1100000 USD
CY2017Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1100000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5495000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6492000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2726000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10539000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
997000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7813000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16786952 shares
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47479879 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16786952 shares
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47479879 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
17000 USD
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
47000 USD
CY2016Q1 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
1665000 USD
CY2017Q1 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
461000 USD
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
209000 USD
CY2016Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
20000 USD
CY2017Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
151000 USD
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-220.00
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-110.00
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1400000 USD
CY2016Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1170000 USD
CY2017Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
69000 USD
CY2016Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
0 USD
CY2017Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
0 USD
CY2016Q1 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-94000 USD
CY2017Q1 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-7000 USD
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1939000 USD
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1158000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
718000 USD
CY2017Q1 us-gaap Goodwill
Goodwill
718000 USD
CY2017Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2016Q1 us-gaap Gross Profit
GrossProfit
-14000 USD
CY2017Q1 us-gaap Gross Profit
GrossProfit
56000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
627000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-175000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-23000 USD
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-317000 USD
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
46000 USD
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
102000 USD
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
195000 USD
CY2016Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
72000 USD
CY2017Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-37000 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
49000 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15000 USD
CY2016Q1 us-gaap Interest Income Other
InterestIncomeOther
0 USD
CY2017Q1 us-gaap Interest Income Other
InterestIncomeOther
1000 USD
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
177000 USD
CY2017Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
261000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
660000 USD
CY2017Q1 us-gaap Inventory Net
InventoryNet
855000 USD
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
382000 USD
CY2017Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
454000 USD
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
101000 USD
CY2017Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
140000 USD
CY2017Q1 us-gaap Inventory Write Down
InventoryWriteDown
19000 USD
CY2015Q3 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P4Y
CY2016Q4 us-gaap Liabilities
Liabilities
2130000 USD
CY2017Q1 us-gaap Liabilities
Liabilities
3721000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5565000 USD
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33865000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1707000 USD
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2172000 USD
CY2016Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
2600000 USD
CY2017Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
10300000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5000000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10000000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3984000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2183000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-3189000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-2887000 USD
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
4249000 USD
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
2266000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4263000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2210000 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
22000 USD
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
23300 USD
CY2016Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
184000 USD
CY2017Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
135000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
126000 USD
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
126000 USD
CY2016Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
817000 USD
CY2017Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
21128000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
143000 USD
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1201000 USD
CY2016Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
0 USD
CY2017Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
45000 USD
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1074000 USD
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-677000 USD
CY2016Q1 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
2000 USD
CY2017Q1 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
602000 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19000 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000 USD
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
247000 USD
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
261000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10000000 USD
CY2016Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10000000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
103000 USD
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
93000 USD
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1772000 USD
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
994000 USD
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
35000 USD
CY2017Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
35000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-98312000 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-101199000 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-101200000 USD
CY2017Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.96
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
447000 USD
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
265000 USD
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
538000 USD
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
114000 USD
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.38
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.81
CY2017Q1 us-gaap Share Price
SharePrice
0.77
CY2016Q1 us-gaap Stock Issued1
StockIssued1
0 USD
CY2017Q1 us-gaap Stock Issued1
StockIssued1
18786000 USD
CY2017Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
18916940 shares
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
3435000 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
30144000 USD
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14796119000 shares
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26853433000 shares
CY2017Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reported amounts of expenses in the financial statements and accompanying notes. Actual results could differ from those</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">estimates. Key estimates included in the financial statements include the valuation of: deferred income tax assets, liability and equity instruments, stock-based compensation, acquired intangibles, contingent earn-out consideration, and allowances for accounts receivable and inventory.</font></div></div>

Files In Submission

Name View Source Status
0001628280-17-005423-index-headers.html Edgar Link pending
0001628280-17-005423-index.html Edgar Link pending
0001628280-17-005423.txt Edgar Link pending
0001628280-17-005423-xbrl.zip Edgar Link pending
capn-20160930.xml Edgar Link completed
capn-20160930.xsd Edgar Link pending
capn-20160930_cal.xml Edgar Link unprocessable
capn-20160930_def.xml Edgar Link unprocessable
capn-20160930_lab.xml Edgar Link unprocessable
capn-20160930_pre.xml Edgar Link unprocessable
capn-20170331x10q.htm Edgar Link pending
ex-31120170331x10q.htm Edgar Link pending
ex-31220170331x10q.htm Edgar Link pending
ex-321201703310x10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending